Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |